Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : North American Vaccine -- Ignore unavailable to you. Want to Upgrade?

To: Don W Stone who wrote (227)	1/21/1998 8:26:00 AM
From: aknahow	Read Replies (1) \| Respond to of 507

Don, not to disagree but when I saw many optimistic post on the merger activity of the big pharmas I wondered how much that distracts them from working on doing smaller deals with biotechs like XOMA. It is possible that they are so big that those in charge of the smaller deals don't get involved at all in the merger process but it is still possible that a collaborative agreement for $100 million or more might be put on hold or become part ofhe merger discussion. So, I am not sure the activity is a pure plus but indeed it seems to have helped prices of most biotechs.